Abstract
EPS6.05 Clinical outcomes in concurrent elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) treated vs. ineligible cohorts in the US Cystic Fibrosis Foundation Patient Registry (CFFPR) during COVID-19
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have